Antimicrobial Resistance Mechanisms among Campylobacter

Abstract EN

Campylobacter jejuni and Campylobacter coli are recognized as the most common causative agents of bacterial gastroenteritis in the world.

Humans most often become infected by ingesting contaminated food, especially undercooked chicken, but also other sources of bacteria have been described.

Campylobacteriosis is normally a self-limiting disease.

Antimicrobial treatment is needed only in patients with more severe disease and in those who are immunologically compromised.

The most common antimicrobial agents used in the treatment of Campylobacter infections are macrolides, such as erythromycin, and fluoroquinolones, such as ciprofloxacin.

Tetracyclines have been suggested as an alternative choice in the treatment of clinical campylobacteriosis but in practice are not often used.

However, during the past few decades an increasing number of resistant Campylobacter isolates have developed resistance to fluoroquinolones and other antimicrobials such as macrolides, aminoglycosides, and beta-lactams.

Trends in antimicrobial resistance have shown a clear correlation between use of antibiotics in the veterinary medicine and animal production and resistant isolates of Campylobacter in humans.

In this review, the patterns of emerging resistance to the antimicrobial agents useful in treatment of the disease are presented and the mechanisms of resistance to these drugs in Campylobacter are discussed.